Home/Filings/4/0001213900-26-005839
4//SEC Filing

Shalom Menachem 4

Accession 0001213900-26-005839

CIK 0001787518other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 7:57 PM ET

Size

10.1 KB

Accession

0001213900-26-005839

Insider Transaction Report

Form 4
Period: 2026-01-15
Shalom Menachem
DirectorCEO10% Owner
Transactions
  • Other

    Common Stock$0.0001 par value per share

    [F1]
    2026-01-16+1,992,0103,242,010 total
  • Other

    Common Stock Purchase Warrants

    [F1]
    2026-01-15+5,018,3595,018,359 total
    Exercise: $1.50From: 2026-01-15Exp: 2031-01-15Common (5,018,359 underlying)
  • Award

    Call Option (to Purchase Common Stock and warrants)

    [F2]
    2026-01-13+1,752,5931,752,593 total
    Exercise: $1.50Common
Footnotes (2)
  • [F1]The securities were issued to the reporting person upon completion of the acquisition by Nukkleus Inc of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc. (the "Star 26") As a result of being a shareholder of Star 26, the Reporting Person received the shares and warrants reported above.
  • [F2]The Reporting Person is a party to the Call Option Agreement dated January 13, 2026 with Esousa Group Holdings LLC ("Esousa") pursuant to which the Reporting Person has the right to purchase from Esousa 498,003 shares of Common Stock and warrants to purchase 1,254,590 shares of Common Stock at a per share exercise price of $1.50. The right shall commence only after Esousa has sold a portion of said securities for gross proceeds equal to $3,000,000 (the "Satisfaction Date") and terminate upon the earlier of the parties agreeing in writing to its termination, when Esousa no longer holds the securities and 60 days after the Satisfaction Date.
Signature
/s/ Menachem Shalom|2026-01-20

Documents

1 file

Issuer

Nukkleus Inc.

CIK 0001787518

Entity typeother

Related Parties

1
  • filerCIK 0002030245

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 7:57 PM ET
Size
10.1 KB